Pacific Edge Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| HOLX | Hologic | Outperform |
8
|
$75.02 | Buy/Sell | $81.06 | 12.64% | 3 | $17.51B |
| QGEN | QIAGEN N.V. | Outperform |
15
|
$45.69 | Buy/Sell | $0.00 | 9.43% | 3 | $9.67B |
| GH | Guardant Health | Buy |
6
|
$25.36 | Buy/Sell | $43.00 | 51.81% | 2 | $2.37B |
| NEO | NeoGenomics | Outperform |
8
|
$14.80 | Buy/Sell | $20.09 | 28.38% | 9 | $1.95B |
| MYGN | Myriad Genetics | Outperform |
6
|
$25.29 | Buy/Sell | $22.08 | -1.15% | 8 | $1.79B |
| VCYT | Veracyte | Outperform |
11
|
$22.88 | Buy/Sell | $32.17 | 31.12% | 4 | $1.61B |
| OPK | OPKO Health | Outperform |
8
|
$1.01 | Buy/Sell | $6.70 | 296.04% | 0 | $1.18B |
| NSTG | NanoString Technologies | - |
7
|
$0.12 | Buy/Sell | $5.02 | -100.00% | 4 | $6.98M |